Signaling pathways
-
BA5312 BQ-788Summary: BQ-788 is a potent, selective receptor antagonist. -
BA5313 ClazosentanSummary: Clazosentan (Ro61-1790) is a selective endothelin A receptor antagonist.
-
BA5314 AtrasentanSummary: Atrasentan (ABT-627) is a potent endothelin receptor antagonist.
-
BA5315 DarusentanSummary: Darusentan (Lu-135252) is a selective endothelin receptor A receptor antagonist.
-
BA5316 TezosentanSummary: Tezosentan (RO610612) is an antagonist of the endothelin receptor.
-
BA5317 Bosentan-d4Summary: Bosentan-d4 is the deuterium substitute for Bosentan.
-
BA5318 SB-209670Summary: SB-209670 is an extremely potent and highly specific non-peptide, subnanomolar endothelin receptor antagonist.
-
BA5319 HCH6-1Summary: HCH6-1 is a potent competitive dipeptide antagonist of the formyl peptide receptor 1.
-
BA5320 BMS-986235Summary: BMS-986235 (LAR-1219) is a selective, orally active agonist of the formylated peptide receptor 2...
-
BA5321 ACT-389949Summary: ACT-389949 is a first-of-its-kind, highly potent and selective agonist of the formyl peptide receptor 2/lipoprotein A4 receptor.